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Abstract
Objectives
In order to investigate the applicability of routine 10s electrocardiogram (ECG) recordings
for time-domain heart rate variability (HRV) calculation we explored to what extent these
(ultra-)short recordings capture the “actual” HRV.
Methods
The standard deviation of normal-to-normal intervals (SDNN) and the root mean square of
successive differences (RMSSD) were measured in 3,387 adults. SDNN and RMSSD were
assessed from (ultra)short recordings of 10s(3x), 30s, and 120s and compared to 240s–
300s (gold standard) measurements. Pearson’s correlation coefficients (r), Bland-Altman
95% limits of agreement and Cohen’s d statistics were used as agreement analysis
techniques.
Results
Agreement between the separate 10s recordings and the 240s-300s recording was already
substantial (r = 0.758–0.764/Bias = 0.398–0.416/d = 0.855–0.894 for SDNN; r = 0.853–
0.862/Bias = 0.079–0.096/d = 0.150–0.171 for RMSSD), and improved further when three
10s periods were averaged (r = 0.863/Bias = 0.406/d = 0.874 for SDNN; r = 0.941/Bias =
0.088/d = 0.167 for RMSSD). Agreement increased with recording length and reached near
perfect agreement at 120s (r = 0.956/Bias = 0.064/d = 0.137 for SDNN; r = 0.986/Bias =
0.014/d = 0.027 for RMSSD). For all recording lengths and agreement measures, RMSSD
outperformed SDNN.
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Conclusions
Our results confirm that it is unnecessary to use recordings longer than 120s to obtain accu-
rate measures of RMSSD and SDNN in the time domain. Even a single 10s (standard ECG)
recording yields a valid RMSSDmeasurement, although an average over multiple 10s
ECGs is preferable. For SDNN we would recommend either 30s or multiple 10s ECGs.
Future research projects using time-domain HRV parameters, e.g. genetic epidemiological
studies, could calculate HRV from (ultra-)short ECGs enabling such projects to be per-
formed at a large scale.
Introduction
Heart rate variability (HRV) quantifies beat-to-beat fluctuations in heart rate and is considered
an index of cardiac parasympathetic nervous system activity [1–3]. In the general population
reduced HRV has been associated with increased risk of coronary heart disease [4], cardiac
mortality [5], and all-cause mortality [6].
HRV is calculated from time series of beat-to-beat heart-rate data [3]. For our study we
focused on two time-domain HRVmeasurements: the Standard Deviation of the normal-to-
normal intervals (SDNN) and the Root Mean Square of Successive Differences (RMSSD)
between adjacent NNs. Both are easy to calculate and among the most widely used indices of
HRV [7]. SDNN estimates overall HRV, while RMSSD estimates short-term components of
HRV [4]. However in both clinical practice and research, ECGs of 10s or 20s are routinely col-
lected and constitute a vast and potentially valuable resource. Additionally, short-term record-
ings are suitable for large scale studies, because they impose a minimal burden on the subject
and can be made under standardized conditions [8].
Currently it is not known to what extent (ultra-)short ECG recordings of 10s to 20s manage
to capture the “actual” HRV of a subject at rest. Only a limited number of studies have specifi-
cally investigated the validity [9,10] and reproducibility [8,11] of (ultra-)short HRV measure-
ments. However, these studies had very small sample sizes (n70 [10]). In addition these
studies used (intra-class) correlation coefficients between two measurements of different
recording lengths, but this does not account for neither the potential differences in means
between two measurements [12,13] nor communicates the degree of the differences [14].
Given these methodological limitations in the existing literature [9–11] we investigated in a
sample of 3,387 subjects to what extent (ultra-)short recordings capture the “actual” HRV. We
evaluated recordings of 10s, 30s, and 120s selected from the longest (gold-standard) recording
of 240s to 300s. SDNN and RMSSD measured from the (ultra-)short recordings were com-
pared to the gold standard [12,13]. In addition to correlation coefficients we calculated Bland-
Altman’s 95% limits of agreement (LoA) and Cohen’s d statistics to evaluate the agreement of
SDNN and RMSSD measured from (ultra-)short recordings and the gold standard.
Methods
Study population
Our study population consisted of subjects from the “Prevention of Renal and Vascular End-
stage Disease” (PREVEND) study, a prospective cohort composed of men and women aged
from 44.8 to 63.2 years living in Groningen, The Netherlands [15,16]. It was initiated to investi-
gate the natural course of increased albuminuria levels and its association to renal and
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cardiovascular disease. PREVEND subjects completed a first survey between 1997–1998. Dur-
ing the second (between 2001–2003) and third (between 2003–2006) screening rounds beat-to-
beat blood pressure recordings were collected during a 15minute supine resting period, which
were used for HRV calculations (details given below). All subjects gave written informed con-
sent. The PREVEND study was approved by the medical ethics committee of the University
Medical Center Groningen and conducted in accordance to the Helsinki Declaration
guidelines.
Measurement procedure
Using a standardized procedure, continuous beat-to-beat pressure recordings on the middle
finger using a Portapres1 pressure recording device (FMS Finapres Medical systems BV,
Amsterdam, The Netherlands) and Beatscope software (Finapres Medical Systems, Amster-
dam, The Netherlands) were used to measure NN-interval time series. The cuff of the Por-
tapres1 was placed on the middle finger of the dominant arm. The subjects were measured in
the supine position in a quiet room at constant temperature (22°C), breathing spontaneously
and holding the Portapres cuff at heart level, and were not allowed to talk or move during the
measurement.
Processing of data
Before HRV analysis the pulse wave data was visually pre-processed to exclude non-sinus
rhythm, ectopic beats, and artifacts, such as premature ventricular beats, electrical ‘noise’, or
aberrant beats. NN-intervals from the beat-to-beat blood pressure signals were detected, with
an accuracy ±5ms. Artifacts were removed and the resulting gaps were interpolated. The NN-
interval detection and interpolation algorithm used has been previously described [17]. When
a recording measured had more than 5% interpolated NN-intervals, the data were considered
invalid and discarded. From these processed beat-to-beat blood pressure signals the deflections
were detected and all intervals in-between these deflections (NN-intervals) were used to calcu-
late SDNN and RMSSD. SDNN and RMSSD were obtained using the CARSPAN 2.0 program
(IECProgramma, Groningen, the Netherlands), which is a software package specifically
designed for cardiovascular spectral analysis [18]. From the 15 min of recorded signal we
selected the last 4 to 5 min with a stationary time series. This recording length of 240s to 300s
of high quality signal was considered the gold-standard recording length. SDNN and RMSSD
were calculated for this total recording length. Three non-overlapping 10s recordings were ran-
domly selected from a subject’s total recording, while periods of 30s and 120s were selected
from the start of the total recording. In addition we also calculated the average SDNN and
RMSSD of the three 10s recordings (Avg10s) (Fig 1). After data processing we had HRV data
of 3,387 subjects that were used for analysis.
Statistical analyses
Prior to the analyses, SDNN and RMSSD data were log-transformed to obtain approximately
normal distributions. Pearson’s correlation coefficients(r) for SDNN and RMSSD were calcu-
lated between the gold-standard recording and the three separate 10s, the Avg10s, the 30s, and
the 120s recordings. However, a correlation coefficient is blind to the possibility of bias caused
by the differences in the mean and/or standard deviation (SD) between the two measurements.
More specific, a strong correlation does not necessarily imply a close agreement. Therefore the
Bland-Altman procedure was used to calculate 95% LoA [12,13]. In contrast to the traditional
Bland-Altman plots we plotted the measurement of the gold standard on the x-axis [19]. The
bias was calculated as the mean difference between the HRV measurements of the gold
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standard and those of the (ultra-)short recording periods. Furthermore, we calculated Cohen’s d
statistics to quantify the bias of the HRVmeasurements of different recording lengths relative to
their within-group variations [14]. This was done by dividing the bias in HRV by the standard
deviation (SD) of the total recording. For example, a Cohen’s d of 0.027 is the difference between
two recording means of 2.7% of the SD of the total recording could be interpreted as a very small
effect (where d = 0.20 is a small, d = 0.50 is a moderate, and d = 0.80 is a large difference) [14,20].
In addition, to measure the reliability of our 10s recording periods we calculated the intra-class
correlation coefficients (ICC; absolute agreement, two-way analysis of variance) between the
three 10s measurements for both RMSSD and SDNN. Stata v11.2 (StataCorp LP, Texas, USA)
was used for all statistical analysis. P-values<0.05 were considered statistical significant.
Simulation study
As a result of our study design, measures based on the (ultra-)short segments are not indepen-
dent from the total (gold standard) period from which they were selected, which automatically
generates an inflation of the correlations, Cohen’s ds, and 95% LoAs that we determine in this
study. Therefore, we conducted a simulation study using a bootstrapping procedure in order to
assess the correlations, 95% LoAs, and Cohen’s d statistics expected under the null hypothesis
of no agreement between the measurements of the (ultra-)short recordings and the remainder
Fig 1. Representation of the 10s, 30s and 120s recordings selected from the total recording period (240s–300s).
doi:10.1371/journal.pone.0138921.g001
Validity of (Ultra-)Short Recordings for HRVMeasurements
PLOS ONE | DOI:10.1371/journal.pone.0138921 September 28, 2015 4 / 15
of the total recording. That is, the only agreement between HRVmeasurements from the
(ultra-)short and total recordings arises from the (ultra-)short recording being part of the total
recording.
The HRV values for the remainders of the total recording (i.e. of length 230-290s for the 10s
recordings, of length 210-270s for the 30s recordings, and of length 120-180s for the 120s
recordings) were approximated by subtracting HRV based on the (ultra-)short recording from
HRV of the total recording using a mathematical formula for decomposing variances. Formula
(1) shows how HRV from a 290s recording is approximated by subtracting HRV from a 10s
recording from a total recording of 300s.
HRV 290sð Þ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
HRVð300sÞ2  ðNð300sÞ  1Þ  HRVð10sÞ2  ðNð10sÞ  1Þ
Nð300sÞ  Nð10sÞ  1
s
; ð1Þ
where N(xs) is the number of NN intervals for the xs recording. Next 3,387 HRV values
from the actual data set of (ultra-)short recordings and 3,387 HRV values from the actual data
set of corresponding remainders were drawn independently of each other with replacement
and then each pair of HRV values was combined to approximate HRV from a total recording
using a mathematical formula for adding independent SDs. For example, to simulate HRV
from a 300s recording under the null hypothesis, HRV from a 10s recording was selected as
well as HRV from a 290s recording and from these two values HRV from a 300s recording was
approximated using Formula (2).
HRV 300sð Þ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
HRVð10sÞ2  ðNð10sÞ  1Þ þ HRVð290sÞ2  ðNð290sÞ  1Þ
Nð10sÞ þ Nð290sÞ  1
s
ð2Þ
Correlation coefﬁcients, 95% LoAs, and Cohen’s ds were computed to determine the agree-
ment of the 10, 30, and 120 NN interval measurements with the total recording under the null
hypothesis. This procedure was repeated 1,000 times and for each of the HRV variables
(SDNN or RMSSD) measured from each of the (ultra-)short recordings (10s, Avg10s, 30s, and
120s) 95% reference ranges were determined for the correlation coefﬁcients, 95% LoAs, and
Cohen’s ds. The observed values were compared to these ranges expecting that the observed
values will show more agreement than expected and hence fall outside the simulated reference
ranges (see Fig 2). An observed value outside the corresponding reference range indicates a sig-
niﬁcant difference (p<0.05).
Results
In our sample of 3,387 subjects the mean age was 53 years and 51% were women. The average
total recording length was 294s (min-max:239-302s) with a total population heart rate average
of 68(SD:±10) beats per minute. At the second screening, our total population had 6.7% of sub-
jects with a recent cardiovascular event, 39% were hypertensive, 7.6% had diabetes mellitus
type 2, 34% had hypercholesterolemia and 22% had chronic kidney disease. Median values for
SDNN and RMSSD were similar for males and females (see Table 1). We observed the usual
strong inverse correlation with age for both SDNN (r = -0.30) and RMSSD (r = -0.28). The
3,387 subjects used in the current study that had good quality HRV measures available consti-
tuted about half of the total sample size of the second screening of PREVEND. As shown in
Table 2 characteristics of the subjects used in the current study were very similar to those of
subjects not used in the current study. Table 3 shows the raw and natural log transformed
SDNN and RMSSD categorized by recording length. It shows that the mean values of RMSSD
and, particularly, SDNN increased for longer recording lengths. This increase was 1.32ms for
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the mean RMSSD (from 28.16 for Avg10s to 29.48 for the total recording), while the mean
SDNN increased 9.94ms (from 25.87 for Avg10s to 35.81 for the total recording).
Pearson’s correlation coefficients
Correlation between a single 10s recording and the gold-standard recording was already sub-
stantial (r = 0.758–0.764 for SDNN; r = 0.853–0.862 for RMSSD) and increased significantly
for Avg10s (r = 0.863 for SDNN; r = 0.941 for RMSSD) [Table 4; Fig 3a]. For both SDNN and
RMSSD the correlations of Avg10s were similar to those of the 30s recordings (r = 0.863 and
0.859, respectively for SDNN; r = 0.941 and 0.932, respectively for RMSSD). Near perfect corre-
lations with the gold standard were found for the measurements of the 120s recording
(r = 0.956 for SDNN and r = 0.986 for RMSSD). Overall the correlations were lower for SDNN
compared to RMSSD, but this difference became smaller with the increase of recording length.
The differences in correlation between SDNN and RMSSD were significant as shown by their
non-overlapping 95%CI.
Bland-Altman plots
Decrease in the bias and in the width of the 95%LoA interval was observed as the recording
length increased (Figs 4 and 5; Table 4) for both SDNN and RMSSD. The three 10s recording
periods revealed similar biases (for SDNN 0.398–0.416 and for RMSSD 0.079–0.096) and also
the 95%LoAs for the three 10s period were similar for both SDNN (widest 95%LoA = -0.386–
1.198) and RMSSD (widest 95%LoA = -0.525–0.716). A slight increase in bias was observed for
Avg10s (SDNN:0.406 and RMSSD:0.088), but the 95%LoA for both SDNN (95%LoA = -0.131–
0.944) and RMSSD (95%LoA = -0.282–0.459) became narrower. For RMSSD the 95%LoA for
the measurements from the 30s recordings were equally wide as for Avg10s and the biases for
RMSSD (30s:0.055; 95%LoA = -0.343–0.453) were also similar, but for SDNN the 30s
Fig 2. Biases and 95% LoAsmilliseconds(ms) of the log-transformed (a) SDNN [in blue] and (b) RMSSD [in red] measured from the recordings with
different time lengths compared to the total recording. The diamonds are the observed bias and the lines represent the intervals defined by the observed
95%LoAs. The bands show the 95% reference ranges of the simulated biases and the dark gray bands show the 95% reference ranges of the upper and
lower 95%LoAs from the simulation. The dotted lines represent the intervals defined by the simulated 95%LoAs. For both SDNN and RMSSD for all recording
lengths the observed biases did not differ from the expectation, but the observed 95%LoAs were much narrower than expected.
doi:10.1371/journal.pone.0138921.g002
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Table 1. Demographic characteristics of all subjects included in the current study at the second screening of the PREVEND cohort.
Variable Total Males Females
N 3387 (100%) 1658 (49%) 1729 (51%)
Age, yrs 53 [44.8–63.2] 53.9 [45.2–64.6] 52.8 [44.3–60.9]
Black race, n 26 (0.8%) 10 (0.6%) 16 (0.9%)
Height, cm 172 (9.6) 179 (7.2) 166 (7.0)
Weight, kg 80 (15) 86 (13) 74 (14)
BMI, kg/m2 27 (4.5) 27 (3.8) 27 (5.0)
WHR 0.90 (0.084) 0.96 (0.066) 0.85 (0.064)
Recent CV eventa 106 (3.1%) 72 (4.3%) 34 (2.0%)
Heart rate, beats/min 68 (10) 67 (10) 70 (9.6)
Blood pressure
SBP, mmHg 127 (19) 131 (18) 123 (19)
DBP, mmHg 74 (9.0) 77 (8.7) 71 (8.5)
MAP, mmHg 93 (12) 96 (12) 90 (12)
Antihypertensive Tx 729 (22%) 378 (23%) 351 (21%)
Hypertensionb 1192 (39%) 639 (44%) 553 (35%)
Diabetes
Fasting glucose, mmol/L 4.8 [4.4–5.3] 5.0 [4.5–5.4] 4.7 [4.4–5.2]
Antidiabetic Tx 107 (3.2%) 59 (3.7%) 48 (2.8%)
Diabetes Mellitusc 222 (7.6%) 116 (8.4%) 106 (6.9%)
Smoking
Never 960 (28%) 396 (24%) 564 (33%)
Former 1415 (42%) 764 (47%) 651 (38%)
Current
<6 cigarettes/day 141 (4.2%) 67 (4.1%) 74 (4.3%)
6–20 cigarettes/day 685 (20%) 335 (20.5%) 350 (21%)
>20 cigarettes/day 141 (4.2%) 73 (4.5%) 68 (4.0%)
Lipids
Total cholesterol, mmol/L 5.5 (1.0) 5.4 (1.0) 5.5 (1.0)
Lipid lowering Tx 296 (9.0%) 163 (1.01%) 133 (7.8%)
Hypercholesterolemiad 1043 (34%) 512 (31%) 531 (31%)
Renal characteristics
Serum creatinine, mmol/L 0.82 (0.21) 0.91 (0.18) 0.74 (0.20)
Serum cystatin-C, mg/L 0.91 (0.20) 0.94 (0.20) 0.88 (0.20)
eGFRe, ml/min/1.73m2 92 (17) 92 (17) 91 (16)
UAE, mg/24h 9.0 [6.2–17] 10 [6.8–23] 8.0 [5.8–14]
CKDf 692 (22%) 427 (26%) 265 (16%)
HRV
SDNN, ms 31.9 [23.8–43.6] 32.0 [23.3–45.1] 31.9 [24.1–42.3]
RMSSD, ms 24.5 [17.1–35.1] 23.4 [16.6–33.8] 25.8 [17.9–36.6]
Data are expressed as mean (sd), number (%), or median [IQR] in case of skewed distributions. BMI body mass index; WHR waist-hip ratio; CV
cardiovascular; SBP systolic blood pressure; DBP diastolic blood pressure; MAP mean arterial pressure; Tx therapy; LDL low density lipoprotein; eGFR
estimated glomerular ﬁltration rate; UAE urinary albumin excretion; CKD chronic kidney disease, HRV heart rate variability; SDNN standard deviation of
normal-to-normal RR-intervals; RMSSD; root mean square of successive differences of adjacent RR-intervals.
a Deﬁned as a clinical diagnosis of any of the following: acute myocardial infarction, (sub)acute ischemic heart disease, coronary artery bypass grafting,
percutaneous transluminal coronary angioplasty, subarachnoid haemorrhage, intracerebral haemorrhage, occlusion/stenosis of the (pre)cerebral arteries,
and other vascular interventions such as percutaneous transluminal angioplasty or bypass grafting of aorta/peripheral vessels.
b Deﬁned as SBP  140mmHg, DBP  90mmHg, or antihypertensive Tx.
c Deﬁned as fasting glucose > 7 mmol/L, or antidiabetic Tx. All cases were type 2 diabetes.
d Deﬁned as total cholesterol  6.21 mmol/L, or lipid lowering Tx.
e Calculated using the CKD-EPI serum creatinine—serum cystatin C equation.
f Deﬁned as either eGFR < 60ml/min/1.73m2 or UAE  30mg/24h.
Smoking was self-reported “never”, “former”, “currently <6”, currently “6–20” or “currently >20”. Tx was reported “yes” “no” or “unknown”.
doi:10.1371/journal.pone.0138921.t001
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Table 2. Demographic characteristics of subjects from the PREVEND cohort that were included in and excluded from our study.
N 6894 (100%) 3387 (49.1%) 3507 (50.9%) n/a
Age, yrs 53 [44.0–63.6] 53 [44.8–63.2] 52.0 [43.2–63.8] 0.020*
Male 3444 (50%) 1658 (49.0%) 1786 (50.9%) 0.101
Black race 64 (0.9%) 26 (0.8%) 38 (1.1%) 0.172
Height, cm 173 (9.5) 172 (9.6) 173 (9.5) 0.033*
Weight, kg 79.9 (14.6) 80.0 (14.7) 79.8 (14.5) 0.470
BMI, kg/m2 26.8 (4.4) 26.9 (4.5) 26.6 (4.3) 0.020*
WHR 0.90 (0.086) 0.90 (0.084) 0.90 (0.087) 0.032*
Recent CV eventa 218 (3.2%) 106 (3.1%) 112 (3.2%) 0.879
Heart rate, beats/min 68.5 (10.1) 68.4 (10.1) 68.5 (10.2) 0.933
Blood pressure
SBP, mmHg 126 (19) 127 (19) 126 (19) 0.264
DBP, mmHg 73 (9.1) 74 (9.0) 73 (9.2) 0.050*
MAP, mmHg 93 (12) 93 (12) 92 (12) 0.230
Antihypertensive Tx 1414 (20.8%) 729 (21.5%) 685 (19.5%) 0.066
Hypertensionb 2380 (38.6%) 1192 (39.1%) 1188 (38.2%) 0.452
Diabetes
Fasting glucose, mmol/L 4.8 [4.4–5.3] 4.8 [4.4–5.3] 4.8 [4.4–5.3] 0.358
Antidiabetic Tx 235 (3.5%) 107 (3.2%) 128 (3.7%) 0.166
Diabetes Mellitusc 454 (7.7%) 222 (7.6%) 232 (7.8%) 0.810
Smoking 0.235
Never 1969 (28.9%) 960 (28.7%) 1009 (29.1%)
Former 2922 (42.9%) 1415 (42.3%) 1507 (43.5%)
Current
<6 cigarettes/day 307 (4.5%) 141 (4.2%) 166 (4.8%)
6–20 cigarettes/day 1346 (19.8%) 685 (20.4%) 661 (19.1%)
>20 cigarettes/day 264 (3.9%) 141 (4.2%) 123 (3.5%)
Lipids
Total cholesterol, mmol/L 5.4 (1.1) 5.5 (1.0) 5.4 (1.1) 0.001*
Lipid lowering Tx 592 (8.8%) 296 (9.0%) 296 (8.7%) 0.335
Hypercholesterolemiad 2055 (33.4%) 1043 (34.4%) 1012 (32.5%) 0.127
Renal characteristics
Serum creatinine, mmol/L 0.83 (0.23) 0.82 (0.21) 0.83 (0.25) 0.218
Serum cystatin-C, mg/L 0.91 (0.21) 0.91 (0.20) 0.91 (0.22) 0.469
eGFRe, ml/min/1.73m2 92 (17) 92 (17) 92 (18) 0.563
UAE, mg/24h 8.8 [6.1–16.5] 9.0 [6.2–17] 8.7 [6.0–16] 0.076
CKDf 1391 (20%) 692 (21.5%) 699 (21.2%) 0.746
Data are expressed as mean (sd), number (%), or median [IQR] in case of skewed distributions. BMI body mass index; WHR waist-hip ratio; CV
cardiovascular; SBP systolic blood pressure; DBP diastolic blood pressure; MAP mean arterial pressure; Tx therapy; LDL low density lipoprotein; eGFR
estimated glomerular ﬁltration rate; UAE urinary albumin excretion; CKD chronic kidney disease;
a Deﬁned as a clinical diagnosis of any of the following: acute myocardial infarction, (sub)acute ischemic heart disease, coronary artery bypass grafting,
percutaneous transluminal coronary angioplasty, subarachnoid haemorrhage, intracerebral haemorrhage, occlusion/stenosis of the (pre)cerebral arteries,
and other vascular interventions such as percutaneous transluminal angioplasty or bypass grafting of aorta/peripheral vessels.
b Deﬁned as SBP  140mmHg, DBP  90mmHg, or antihypertensive Tx.
c Deﬁned as fasting glucose > 7 mmol/L, or antidiabetic Tx. All cases were type 2 diabetes.
d Deﬁned as total cholesterol  6.21 mmol/L, or lipid lowering Tx.
e Calculated using the CKD-EPI serum creatinine—serum cystatin C equation.
f Deﬁned as either eGFR < 60ml/min/1.73m2 or UAE  30mg/24h.
Smoking was self-reported “never”, “former”, “currently <6”, currently “6–20” or “currently >20”. Tx was reported “yes” “no” or “unknown”.
Two-sided p-values were calculated using t-tests, Mann-Whitney U-tests, and χ2-tests where applicable.
* shows statistically signiﬁcant: p-value  0.05
doi:10.1371/journal.pone.0138921.t002
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recordings both the bias and 95%LoA improved substantially (0.240; 95%LoA = -0.300–0.780)
compared to those from the Avg10s recording. An almost negligible bias was found for the
120s recordings for both HRV traits, where SDNN had a bias of 0.064 (95%LoA = -0.059–
0.069) and RMSSD of 0.014 (95%LoA = -0.011–0.017) [Table 4]. Overall the biases and the
intervals defined by the 95%LoA were smaller for RMSSD compared to SDNN.
Cohen’s d statistics
For the three 10s recording periods compared to the gold standard Cohen’s d was small for
RMSSD (d = 0.150–0.171), but large for SDNN (d = 0.855–0.894) (Table 4; Fig 3b). For the
Avg10s recordings, similar Cohen’s d were found (SDNN: d = 0.874; RMSSD: d = 0.167).
Table 3. Descriptive statistics of raw and natural log transformed SDNN and RMSSD of 3,387 individuals categorized by recording period.
Recording SDNN mean (SD) lnSDNN mean (SD) RMSSD mean (SD) lnRMSSD mean (SD)
10s recording 1 25.48 (18.35) 3.05 (0.60) 27.78 (23.27) 3.13 (0.59)
10s recording 2 26.18 (19.99) 3.07 (0.61) 28.57 (25.92) 3.15 (0.61)
10s recording 3 25.95 (19.04) 3.06 (0.61) 28.16 (23.78) 3.14 (0.60)
Avg10s 25.87 (16.86) 3.06 (0.53) 28.17 (22.17) 3.14 (0.55)
30s recording 29.14 (17.87) 3.23 (0.53) 28.22 (21.99) 3.17 (0.55)
120s recording 33.96 (18.64) 3.40 (0.49) 29.15 (22.43) 3.21 (0.53)
total recording 35.81 (18.57) 3.47 (0.46) 29.48 (22.51) 3.23 (0.53)
s: seconds; SDNN: standard deviation of normal-to-normal intervals in milliseconds; RMSSD: root mean square of successive differences in milliseconds;
lnSDNN: natural logarithm of SDNN; lnRMSSD: natural logarithm of RMSSD; SD: Standard Deviation; Avg10s: the average of the measurements from the
three 10s recordings.
doi:10.1371/journal.pone.0138921.t003















































































































CI: conﬁdence interval; LoA: limits of agreement; s: seconds; Avg10s: the average of the measurements from the three 10s recordings
doi:10.1371/journal.pone.0138921.t004
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Cohen’s d for the 30s recording periods compared to the gold standard was moderate for
SDNN (d = 0.516) and small for RMSSD (d = 0.104) and it became even smaller for the mea-
surements from the 120s recordings. For SDNN Cohen’s d showed a small difference
(d = 0.137) and for RMSSD it was almost negligible (d = 0.027).
Fig 3. Agreement statistics of the natural logarithm of SDNN (blue dashed line) and RMSSD (red solid
line) measured from the recordings with different time lengths compared to the total recording.
Agreement is measured using (a) Pearson’s correlation coefficient, and (b) Cohen’s d statistic. The
error bars (orange for RMSSD; green for SDNN) represent 95% confidence intervals of the mean. The red
solid line band (representing RMSSD) and the blue dashed line band (representing SDNN) are the expected
values under the null hypothesis as a result of our simulation analysis. For both SDNN and RMSSD for all
recording lengths the observed correlations were considerably larger than expected under the null
hypothesis, but the Cohen’s ds for both SDNN and RMSSD did not differ from the expectation.
doi:10.1371/journal.pone.0138921.g003
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Intra-class correlation coefficients
To measure the reliability of our three 10s recording periods we calculated their ICCs for
RMSSD and SDNN (Table 5). The ICC was modest between the three 10s recordings for
SDNN (0.657–0.670) and improved for RMSSD (0.740–0.751).
Discussion
In order to investigate the utility of routine 10s ECG recordings for HRV calculation in large-
scale epidemiologic studies we evaluated the agreement of SDNN and RMSSD between (ultra-)
short recordings and a gold-standard recording of 240s to 300s in 3,387 adults. We showed
that RMSSD consistently outperformed SDNN. RMSSD measured from recordings of only 10s
in length are already reliable and good proxies for those measured from longer recording
lengths (240s-300s), in particular when the measurements from multiple 10s recordings are
averaged. For SDNN the measurements from 10s recordings were reliable, but although they
correlated moderately (for the single recordings) to strongly (for Avg10s) with the gold stan-
dard, agreement was poor in both cases (i.e. Cohen’s d close to 1) and hence are bad proxies.
For SDNN measured from 30s recordings the agreement with the gold standard was still only
moderate, but sufficient to yield reliable estimates of “actual” SDNN. SDNN and RMSSD mea-
sured from 120s recordings were both in high agreement with the gold-standard recordings.
Our findings that RMSSD measured from 10s recordings is a good proxy for the “actual”
RMSSD, but that this doesn’t hold for SDNN, are in line with previous studies [8–11]. All of
Fig 4. Measurement error of the log transformed values for SDNN (blue dots) calculated as the difference between the total recording and: (a) a
10s recording; (b) the average of the three 10s recording; (c) the 30s recording; (d) the 120s recording. The x-axis is the log transformed SDNN of the
total block and the y-axis is the bias of the (ultra-)short recording for log transformed SDNN compared to the gold standard. The grey shaded area represents
the interval between the 95%LoA and the white line represents the bias. The black horizontal line is the reference line of no bias (y = 0).
doi:10.1371/journal.pone.0138921.g004
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these also observed that measurements from ultra-short recordings yield good estimates of
RMSSD, while for SDNN the agreement is not sufficient to provide reliable estimates for the
“actual” SDNN. In addition we and others observed that the correlation or agreement increased
with an increase of the recording length for RMSSD and especially for SDNN [10,11]. The high
dependence of SDNN on recording length is to be expected because SDNN reflects the total
power of all HRV frequency components combined whereas RMSSD is a reflection of high fre-
quency HRV components only [3]. Furthermore in line with our findings others have shown
that averaging HRV measures obtained from sequential time periods reduces the error
imposed by the analysis of very short segments [8,11]. We found that the reliability of the three
individual 10s recording periods was substantial, in particular for RMSSD.
In our study we chose to extract the (ultra-)short recordings from the total recording length
to specifically address our research question whether HRV measured from (ultra-)short
Fig 5. Measurement error of the log transformed values for RMSSD (red dots) calculated as the difference between the total recording and: (a) a
10s recording; (b) the average of the three 10s recording; (c) the 30s recording; (d) the 120s recording. The x-axis is the log transformed RMSSD of
the total block and the y-axis is the bias of the (ultra-)short recording for log transformed RMSSD compared to the gold standard. The grey shaded area
represents the interval between the 95%LoA and the white line represents the bias. The horizontal black line is the reference line of no bias (y = 0).
doi:10.1371/journal.pone.0138921.g005
Table 5. Interclass correlation coefficients for SDNN and RMSSD between the three different 10s recordings.
10s recording1 vs. 10s recording2 (95% CI) 10s recording1 vs. 10s recording3 (95% CI) 10s recording2 vs. 10s recording3 (95% CI)
SDNN 0.657 (0.638–0.676) 0.668 (0.649–0.687) 0.670 (0.651–0.689)
RMSSD 0.740 (0.725–0.756) 0.751 (0.736–0.766) 0.746 (0.731–0.761)
CI: conﬁdence interval
doi:10.1371/journal.pone.0138921.t005
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recordings reflect the “actual” HRV. Our design differs from that of Schroeder and colleagues
[11], who measured HRV at sequential time periods. Their design is more suited to assess the
repeatability (or reliability) of HRV measurements, while our study design reflects our focus on
the validity of (ultra-)short recordings for HRV measurements in the time domain (SDNN,
RMSSD) compared to a gold-standard recording period of 240s to 300s. A consequence of our
study design is that the measurements of the (ultra-)short recordings are not independent of
the total recording and hence correlations and agreement measures are expected to be inflated.
Nevertheless for both HRV measures all observed correlations were significantly higher and all
95%LoAs significantly smaller than those simulated under the null hypothesis supporting the
validity of HRV measurements based on (ultra-)short recordings. The biases and Cohen’s d for
both HRV measures did not differ from the expectation. This can be explained by the fact that
the distributions of the simulated HRV measures from the (ultra-)short and total recordings
are similar to those of the observed ones, leading to similarmean differences between the HRV
measurements of the gold standard and those of the different (ultra-)short recording periods.
However, the variation in those paired differences between the observed measurements of the
(ultra-)short segments and those of the total recording is smaller than from the respective
paired differences of the simulated measurements, explaining the much higher correlation and
tighter 95%LoAs.
In this study we analyzed a general population in which the mean age was 53 years and both
sexes were included [15,16]. Previous studies [8–11] only included healthy individuals and
Dekker et al. [8] further limited their study population to young men (mean ± SD age 25.9
±3.8years), thereby reducing the generalizability of their results even more. Therefore our
results are more representative of the general population. However, 10s ECGs in cases with car-
diac arrhythmias should be used with caution because given the very low number of beats in
10s, one artefact caused by cardiac arrhythmia will make up about 5% of the total duration of
the recording depending on the heart rate. Therefore for calculating RMSSD and SDNN we
suggest the following criteria: (a) one artefact (of any kind such as detection failure or arrhyth-
mia, harmless or not) at the beginning or at the end of a recording should be excluded and the
remaining part of the segment should be used, and (b) other artefacts, not at the beginning or
at the end, or more than one, means the exclusion of the entire segment. This is because we
would need a continuous segment to calculate the successive differences (i.e. SDNN and
RMSSD) and one interruption would imply a great loss of successive differences.
A major strength of our study was the large sample size of 3,387 subjects, which allowed for
precise estimates of agreement measures between different recording periods. Furthermore the
significance of our study is reinforced by our statistical approach. We calculated not only Pear-
son’s correlation coefficients to measure the strength of linear association between the record-
ings, but also used Bland-Altman’s statistics [12,13] and Cohen’s d [14] to evaluate the degree
of bias. As pointed out by Altman and Bland correlation coefficients are not sufficient to dem-
onstrate the agreement of measurements [12, 13]. No previous studies have used these different
agreement analysis techniques. The importance of considering measurements of differences is
demonstrated when comparing our results of the Pearson’s correlation coefficients and
Cohen’s d statistics. For instance a substantial decrease in Cohen’s d statistic from Avg10s to
30s is shown for SDNN, while the Pearson’s correlation coefficients remains the same. There-
fore, only considering Pearson’s correlation coefficient results for SDNN would lead to an erro-
neous interpretation.
Unlike other studies [8–11] that also measured frequency domain HRV parameters such as
the high frequency (HF) component we limited our study to time domain parameters RMSSD
and SDNN. This was because ECGs of less than 60s duration are not sufficient to assess the HF
components and ECGs of at least 120s should be used to address the low frequency
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components [1–3]. Therefore our conclusions do not apply to HRV parameters in the fre-
quency domain.
An important implication of our study is that 10s ECG recordings could be used for calcu-
lating time-domain HRV parameters, particularly RMSSD, in future epidemiologic studies. In
standard in-clinic evaluation of heart rate dynamics, 300s is the recommended length of mea-
surement [3]. Nevertheless, 10s recordings from 12-lead ECGs are already commonly used to
detect resting abnormalities in interval lengths, wave morphology and segment elevation/
depressions [10] and have already shown their usefulness as diagnostic tool [5,6,21]. For exam-
ple, reduced HRVmeasured from three 10s ECG recordings was recently found to be associ-
ated with an increased incidence of heart failure [21]. An example of our findings applicability
is genome-wide association studies (GWAS), where large sample sizes are needed to detect
small effects of genetic variants. A large number of cohorts may have short ECG recordings
available but may not (yet) have measured RMSSD (and SDNN). The increase in sample size
when using RMSSD (and SDNN) from these cohorts in a GWAS will most likely outweigh the
loss in accuracy of the phenotype measurements and hence permit the identification of more
genetic variants.
In summary, from our unprecedented large sample size, the selection of our (ultra-)short
recording from our total recording, our careful data processing and our sophisticated statistical
analysis we can conclude that particularly RMSSD from (ultra-)short recordings manages to
capture HRV well. Even a single 10s (standard) ECG recording yields a valid RMSSD measure-
ment, although averaging over multiple 10s ECGs is preferable. For SDNN we would recom-
mend recordings of at least 30s or, if not available, multiple 10s ECGs. In addition, our study
suggests that it is unnecessary to use recordings longer than 120s to obtain accurate measures
of RMSSD and SDNN.
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